Sophia Genetics's Total Assets for the quarter that ended in Mar. 2026 was $157.00 Mil.
Warning Sign:
If a company builds assets at 19% a year, faster than its revenue growth rate of 13.6% over the past 5 years, it means that the company may be getting less efficient.
During the past 12 months, Sophia Genetics's average Total Assets Growth Rate was 17.20% per year.
During the past 3 years, the average Total Assets Growth Rate was 12.40% per year.
During the past 5 years, the average Total Assets Growth Rate was 19.00% per year.
During the past 8 years, Sophia Genetics's highest 3-Year average Total Assets Growth Rate was 35.00%. The lowest was 11.00%. And the median was 25.20%.
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Sophia Genetics's Asset Turnover for the quarter that ended in Mar. 2026 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Sophia Genetics Total Assets Related Terms
Sophia Genetics Total Assets Historical Data
* Premium members only.
The historical data trend for Sophia Genetics's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Sophia Genetics's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sophia Genetics (SOPH) has a Total Assets of $157.00 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Sophia Genetics and its competitors.
Is Sophia Genetics' Total Assets too high?
Sophia Genetics' current Total Assets is $157.00 Mil. Overall, Sophia Genetics has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sophia Genetics' Total Assets compare to WEAV and NRC?
Sophia Genetics' Total Assets of $157.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Healthcare Providers & Services company?
A good Total Assets depends on the Healthcare Providers & Services industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Sophia Genetics and its competitors. Sophia Genetics's current Total Assets is $157.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sophia Genetics stock overvalued right now?
Based on GuruFocus' analysis, Sophia Genetics (SOPH) is currently considered Fairly Valued. The stock's GF Value™ is $5.04, compared to a current price of $5.36 — trading 6.3% above its estimated fair value. The current Total Assets is $157.00 Mil. Sophia Genetics' overall GF Score™ is 73/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Sophia Genetics (SOPH), the current Total Assets is $157.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sophia Genetics (SOPH) Overvalued in 2026?
Based on GuruFocus' analysis, Sophia Genetics stock appears to be overvalued.
The current stock price of $5.36 is trading 6.3% above its estimated GF Value™ of $5.04.
GuruFocus considers Sophia Genetics to be Fairly Valued.
Key valuation signals for SOPH:
Total Assets: $157.00 Mil
GF Value™: $5.04 vs. price of $5.36 (6.3% above fair value)
No single metric tells the full story. See the SOPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
73GF Score
Get the complete analysis for SOPH
Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SOPH has been successfully added to your 
